Back to results
US 2016/0228408 A1Published application
Inhibitors of CD40-TRAF6 Interaction
AssigneesLudwig-Maximilians-Universitaet Muenchen, Maastricht University, Academisch Ziekenhuis Maastricht
InventorsEsther LUTGENS, Christian WEBER, Gerry NICOLAES
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds acting as selective inhibitors of CD40-TRAF6 interaction, their use as medicaments and their use in the treatment of (chronic) inflammatory diseases. The present invention also relates to pharmaceutical compositions comprising these compounds.
Claims8
A pharmaceutical composition comprising a compound having a formula selected from the group consisting of
- or a pharmaceutically acceptable salt thereof
- and at least one pharmaceutically acceptable carrier, diluent and/or excipient.
Dependencies are inferred from the claim text.